Literature DB >> 1578450

The arthritis of ulcerative colitis: clinical and genetic aspects.

R Scarpa1, A del Puente, A D'Arienzo, C di Girolamo, G della Valle, A Panarese, E Lubrano, P Oriente.   

Abstract

Seventy-nine consecutive patients with active ulcerative colitis were studied to establish the prevalence and clinical features of articular involvement. HLA typing for A and B loci was performed. Forty-nine patients showed an articular involvement (62%). Three different clinical patterns were identified: ankylosing spondylitis occurring in 20 subjects; peripheral arthritis in 15; unclassifiable spondylitis in 14. When compared to the general population in our area, patients with colitis showed a significantly higher prevalence of the HLA-A1 (p less than 0.005), B21 (p less than 0.001) and B27 (p less than 0.05); among patients with colitis, those with arthritis revealed higher frequency of HLA-B27 (p less than 0.05). Our study reveals a high prevalence of unclassifiable spondylitis during ulcerative colitis, and suggests a new approach to the classification of seronegative spondarthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1578450

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Liaison between rheumatoid arthritis and ulcerative colitis.

Authors:  Yusuf Aydin; Levent Ozçakar; Mehmet Yildiz; Ayşen Akinci
Journal:  Rheumatol Int       Date:  2002-12-18       Impact factor: 2.631

2.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Jonathan S Levine; Robert Burakoff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

3.  Development of ulcerative colitis during the course of rheumatoid arthritis: Association with selective IgA deficiency.

Authors:  Yuki Asada; Hajime Isomoto; Saburo Shikuwa; Chun Yang Wen; Eiichiro Fukuda; Masaru Miyazato; Kenta Okamoto; Takashi Nakamura; Hitoshi Nishiyama; Yohei Mizuta; Kiyoshi Migita; Masahiro Ito; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

4.  The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

Authors:  Nuran Turkcapar; Murat Toruner; Irfan Soykan; Olcay Tiryaki Aydintug; Hulya Cetinkaya; Nursen Duzgun; Ali Ozden; Murat Duman
Journal:  Rheumatol Int       Date:  2005-09-01       Impact factor: 2.631

Review 5.  Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology.

Authors:  Rodolfo Perez-Alamino; Hernan Maldonado-Ficco; José A Maldonado-Cocco
Journal:  Clin Rheumatol       Date:  2015-11-17       Impact factor: 2.980

6.  Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.

Authors:  Carmen Stolwijk; Marieke Pierik; Robert Landewé; Ad Masclee; Astrid van Tubergen
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

Review 7.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations.

Authors:  Cristina Costa Duarte Lanna; Maria de Lourdes Abreu Ferrari; Sidney Lemos Rocha; Evaldo Nascimento; Marco Antônio Parreiras de Carvalho; Aloísio Sales da Cunha
Journal:  Clin Rheumatol       Date:  2007-12-21       Impact factor: 2.980

Review 9.  Epidemiology of spondyloarthritis.

Authors:  Carmen Stolwijk; Annelies Boonen; Astrid van Tubergen; John D Reveille
Journal:  Rheum Dis Clin North Am       Date:  2012-08       Impact factor: 2.670

Review 10.  Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.

Authors:  Carlo Salvarani; Walter Fries
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.